WHO ICTRP trial
Prospective, open-label, multicenter, international study of mifepristone for…
EUCTR2006-004679-36-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-004679-36-FR |
|---|---|
| Public title | Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. - HRA052015 in EAS |
| Scientific title | Prospective, open-label, multicenter, international study of mifepristone for symptomatic treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. - HRA052015 in EAS |
| Primary sponsor | Laboratoire HRA Pharma |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France;Netherlands;Germany;Italy |
| Conditions | Treatment of Cushing's syndrome caused by ectopic Adrenal Corticotrophin Hormone (ACTH) secretion. MedDRA version: 8.1 Level: LLT Classification code 10014155 Term: Ectopic corticotrophin syndrome |
| Interventions | Product Code: HRA052015 Pharmaceutical Form: Tablet INN or Proposed INN: mifepristone CAS Number: 84371-65-3 Other descriptive name: 17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one Concentration unit: mg… |
| Registration date | Sep 29, 2006 |
| Target size | 22 |
| Secondary IDs | 05 2015-001;None |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: